{"id":"W2047070488","doi":"10.1111/j.1365-2036.2005.02336.x","title":"A randomized, double‐blind, placebo‐controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, in patients with corticosteroid‐dependent Crohn's disease","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; University of Toronto; Robarts Clinical Trials; Université de Montréal; University of Calgary; Western University","funders":"","keywords":"Medicine; Corticosteroid; Placebo; Internal medicine; Gastroenterology; Prednisolone; Crohn's disease; Clinical endpoint; Randomized controlled trial; Adverse effect; Surgery; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00148564,0.001484189,0.003296293,0.0003742531,0.0005255102,0.0008335313,0.0009416043,0.001895872,0.005382183],"category_scores_gemma":[0.001952486,0.000687137,0.0008945484,0.0004187258,0.001736962,0.0009089586,0.0004069694,0.00227481,0.001034876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005014957,"about_ca_system_score_gemma":0.001165053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006093375,"about_ca_topic_score_gemma":0.001067936,"domain_scores_codex":[0.999299,0.0003481528,0.00005736149,0.0001366674,0.00006163622,0.00009709314],"domain_scores_gemma":[0.9989358,0.0003163413,0.0002602021,0.00006487576,0.00006945433,0.0003533933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9799069,0.004828892,0.000431423,0.0006391266,0.0003655554,0.0000463209,0.00004298572,0.0001351968,0.002722845,0.00006223832,0.0004671642,0.01035149],"study_design_scores_gemma":[0.9771919,0.02150293,0.0006613384,0.00001425984,0.0001002133,0.00001992546,0.000007484428,0.0001044132,0.0001755031,0.0000261231,0.0001921633,0.000003740172],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845085,0.007004498,0.0007620104,0.0007391535,0.0008708878,0.003659241,0.0005332741,0.0001303068,0.001792159],"genre_scores_gemma":[0.9841101,0.004427283,0.001601458,0.001288432,0.0007435639,0.005197335,0.0006602542,0.00001993324,0.001951631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005382183,"threshold_uncertainty_score":0.01800519,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01722561005087141,"score_gpt":0.3066494488705653,"score_spread":0.2894238388196939,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}